ABBOTT LABORATORIES — Director's Dealing 2018

Jun 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2018-06-05

Reporting Person: Funck Robert E (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-05	Common shares without par value	M	12800	$26.015	Acquired	117293	Direct
2018-06-05	Common shares without par value	F	8613	$63.02	Disposed	108680	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-05	Option (right to buy)	$26.015	M	12800	Disposed	2019-02-19	Common shares (12800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	17082	Indirect
Common shares without par value	500	Indirect
Common shares without par value	500	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of June 5, 2018.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.